"id","uuid:ID","description","instanceType","identifier","name","label","text"
"EligibilityCriterion_1","fdbde651-4c10-4286-b6eb-6e0538bfac91","The study age criterion","EligibilityCriterion","1","Age Criteria","","Subjects shall be between [min_age] and [max_age]"
"EligibilityCriterion_2","0899aaef-f558-4e01-87ef-0c9470cf3a15","The study population criterion","EligibilityCriterion","2","Pop Criteria","","[StudyPopulation] as defined by the NINCDS and the ADRDA guidelines (Attachment LZZT.7)"
"EligibilityCriterion_3","a3e1801c-a1f9-4669-bb33-6516124bccdd","The study diagnosis criterion","EligibilityCriterion","3","Diag Criteria","","[Activity1] score of 10 to 23"
"EligibilityCriterion_4","fa47d434-7d75-4df5-affa-5590eadddaf2","The previous xanomeline TTS criterion","EligibilityCriterion","9","Previous Criteria","","Persons who have previously completed or withdrawn from this study or any other study investigating xanomeline TTS or the oral formulation of xanomeline."
